Literature DB >> 5448778

Haemolytic-uraemic syndrome treated with heparin.

M W Moncrieff, E F Glasgow.   

Abstract

Three children with the haemolytic-uraemic syndrome were treated with intravenous heparin. Peritoneal dialysis was required for two of them, one of whom died after 26 days of therapy. Renal biopsy specimens from the two survivors showed widespread glomerular disease, which appeared permanent in one case, but only occasional thrombi. It is suggested that heparin therapy, by preventing further intrarenal thrombosis, allowed the normal fibrinolytic mechanisms to remove previously formed thrombi.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5448778      PMCID: PMC1701113          DOI: 10.1136/bmj.3.5716.188

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  14 in total

1.  THE HEMOLYTIC-UREMIC SYNDROME.

Authors:  C GIANANTONIO; M VITACCO; F MENDILAHARZU; A RUTTY; J MENDILAHARZU
Journal:  J Pediatr       Date:  1964-04       Impact factor: 4.406

2.  Haemolytic-uraemic syndrome: survival after prolonged oliguria.

Authors:  P Sharpstone; R G Evans; M O'Shea; L Alexander; H A Lee
Journal:  Arch Dis Child       Date:  1968-12       Impact factor: 3.791

3.  Haemolytic-uraemic syndrome.

Authors:  L Monnens; E Schretlen
Journal:  Lancet       Date:  1968-09-28       Impact factor: 79.321

4.  Heparin therapy in the haemolytic-uraemic syndrome.

Authors:  G S Gilchrist; E Lieberman; H Ekert; R N Fine; C Grushkin
Journal:  Lancet       Date:  1969-06-07       Impact factor: 79.321

5.  Haemolytic-uraemic syndrome and heparin therapy.

Authors:  J Katz; A Lurie; B Kaplan
Journal:  Lancet       Date:  1969-09-27       Impact factor: 79.321

6.  The hemolytic-uremic syndrome. Renal status of 76 patients at long-term follow-up.

Authors:  C A Gianantonio; M Vitacco; F Mendilaharzu; G Gallo
Journal:  J Pediatr       Date:  1968-06       Impact factor: 4.406

7.  Hemolytic-uremic syndrome. Clinical and pathological considerations.

Authors:  E Lieberman; E Heuser; G N Donnell; B H Landing; G D Hammond
Journal:  N Engl J Med       Date:  1966-08-04       Impact factor: 91.245

8.  Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment.

Authors:  C Merskey; G J Kleiner; A J Johnson
Journal:  Blood       Date:  1966-07       Impact factor: 22.113

9.  [Hemolytic-uremic syndrome of infancy: 27 clinical and anatomic observations].

Authors:  R Habib; H Mathieu; P Royer
Journal:  Nephron       Date:  1967       Impact factor: 2.847

Review 10.  Bleeding due to increased intravascular blood coagulation. Hemorrhagic syndromes caused by consumption of blood-clotting factors (consumption-coagulopathies).

Authors:  F Rodríguez-Erdmann
Journal:  N Engl J Med       Date:  1965-12-16       Impact factor: 91.245

View more
  9 in total

Review 1.  Streptokinase: a review of its clinical pharmacology, mechanism of action and therapeutic uses.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1973       Impact factor: 9.546

Review 2.  Intravascular coagulation.

Authors:  P T Flute
Journal:  Postgrad Med J       Date:  1972-06       Impact factor: 2.401

3.  [Kidney transplantation in the haemolytic-uremic syndrome].

Authors:  J Eigler; K Finke; G Gröschel; E Held; F W Eigler; K Engelking; A Bohle
Journal:  Klin Wochenschr       Date:  1972-07-01

4.  Coagulation studies in haemolytic uraemic syndrome.

Authors:  M L Willoughby; A V Murphy; S McMorris; F G Jewell
Journal:  Arch Dis Child       Date:  1972-10       Impact factor: 3.791

5.  Successful treatment of post-partum renal failure with heparin.

Authors:  I Timor-Tritsch; O S Better; I Tatarsky; C Chaimowitz; A Peretz; H Abramovici
Journal:  Br Med J       Date:  1970-10-24

6.  Pregnancy, subarachnoid haemorrhage, and the intravascular coagulation syndrome.

Authors:  J R Heron; E C Hutchinson; W N Boyd; G M Aber
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-05       Impact factor: 10.154

7.  Local 'Schwartzman equivalent' reaction in active chronic hepatitis.

Authors:  M J Whelton
Journal:  Gut       Date:  1972-01       Impact factor: 23.059

8.  An evaluation of treatment with heparin in the haemolytic-uraemic syndrome successfully treated by peritoneal dialysis.

Authors:  M G Coulthard
Journal:  Arch Dis Child       Date:  1980-05       Impact factor: 3.791

9.  Thrombolytic therapy in haemolytic--uraemic syndrome.

Authors:  J Stuart; M H Winterborn; R H White; R M Flinn
Journal:  Br Med J       Date:  1974-07-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.